Cited by 1,921Cancer-related Molecular PathwaysGenomics and Chromatin DynamicsDNA Repair Mechanisms

The DOI matches its Crossref record; 201 of the 201 references it cites were found in a registry or an index.

Transcriptional control of human p53-regulated genes

Riley, Todd, Sontag, Eduardo, Chen, Patricia, Levine, Arnold·2008·Nature Reviews Molecular Cell Biology

Open this paper in CoChat — free account

Abstract

The p53 protein regulates the transcription of many different genes in response to a wide variety of stress signals. Following DNA damage, p53 regulates key processes, including DNA repair, cell-cycle arrest, senescence and apoptosis, in order to suppress cancer. This Analysis article provides an overview of the current knowledge of p53-regulated genes in these pathways and others, and the mechanisms of their regulation. In addition, we present the most comprehensive list so far of human p53-regulated genes and their experimentally validated, functional binding sites that confer p53 regulation.

Integrity signals

Registry

Crossref · 10.1038/nrm2395

Cites

201 of 201 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Self-citation
Surfing the p53 network
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · cited 1×
“These include several types of DNA damage: telomere shortening, hypoxia, mitotic spindle damage, heat or cold shock, unfolded proteins, improper ribosomal biogenesis, nutritional deprivation in a transformed cell, and even the activation of some oncogenes by mutatio”
BackgroundSelf-citation
Profile hidden Markov models
Eddy, S. R. (1998) · Bioinformatics · doi:10.1093/bioinformatics/14.9.755 · Cited by 5,515
Sequence logos: a new way to display consensus sequences
Schneider, T. D., & Stephens, R. M. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.20.6097 · Cited by 3,354
Biological Sequence Analysis
Durbin, R. M., Eddy, S. R., Krogh, A., & Mitchison, G. (1998) · Cambridge University Press eBooks · doi:10.1017/cbo9780511790492 · Cited by 3,255
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,559 · cited 1×
“On the basis of X-ray crystallography studies of the p53 DNA-binding core domain bound to a p53-RE DNA sequence, the most important bases for interactions with the p53 protein are the central RCWWGY, which come into close contact with the amino acids from the p53 core domai”
Background
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Minucci, S., & Pelicci, P. G. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1779 · Cited by 2,234
Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6
Yonish-Rouach, E., Resnftzky, D., Lotem, J., Sachs, L., Kimchi, A., & Oren, M. (1991) · Nature · doi:10.1038/352345a0 · Cited by 2,079
Maximum Entropy Modeling of Short Sequence Motifs with Applications to RNA Splicing Signals
Yeo, G. W.-M., & Burge, C. B. (2004) · Journal of Computational Biology · doi:10.1089/1066527041410418 · Cited by 2,042

Flagged first, then by citations

Show all 201 references

Sorted by citations

Items 801–900 of 1,000

Human ex vivo prostate tissue model system identifies ING3 as an oncoprotein
McClurg, U. L., Nabbi, A., Ricordel, C., Korolchuk, S., McCracken, S. R., Heer, R., Wilson, L., Butler, L. M., Irving, B. K., Pedeux, R., et al. (2018) · British Journal of Cancer · doi:10.1038/bjc.2017.447 · Cited by 33
The Tumor Suppressor p53 Transcriptionally Regulates cGKI Expression during Neuronal Maturation and Is Required for cGMP-Dependent Growth Cone Collapse
Tedeschi, A., Nguyen, T. N., Steele, S. U., Feil, S. C., Naumann, U., Feil, R., & Giovanni, S. D. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4416-09.2009 · Cited by 32
Silencing of CD24 Enhances the PRIMA-1–Induced Restoration of Mutant p53 in Prostate Cancer Cells
Zhang, W., Yi, B., Wang, C., Chen, D., Bae, S., Wei, S., Guo, R., Lu, C., Nguyen, L. L. H., Yang, W., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1927 · Cited by 32
Period2 downregulation inhibits glioma cell apoptosis by activating the MDM2-TP53 pathway
Zhanfeng, N., Chengquan, W., Hechun, X., Jun, W., Lijian, Z., Ma, D., Wenbin, L., & Lei, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.8439 · Cited by 33
Platycodin D, a metabolite of Platycodin grandiflorum, inhibits highly metastatic MDA-MB-231 breast cancer growth in vitro and in vivo by targeting the MDM2 oncogene
Kong, Y., Lu, Z., Wang, J., Zhou, R., Guo, J., Liu, J., Sun, H., He, W., Song, W., Yang, J., et al. (2016) · Oncology Reports · doi:10.3892/or.2016.4935 · Cited by 33
Hedgehog inhibitor sonidegib potentiates 177Lu-octreotate therapy of GOT1 human small intestine neuroendocrine tumors in nude mice
Spetz, J. K. E., Langen, B., Rudqvist, N.-P., Parris, T. Z., Helou, K., Nilsson, O., & Forssell-Aronsson, E. B. (2017) · BMC Cancer · doi:10.1186/s12885-017-3524-x · Cited by 32
A Circular RNA from the MDM2 Locus Controls Cell Cycle Progression by Suppressing p53 Levels
Chaudhary, R., Muys, B. R., Grammatikakis, I., De, S., Abdelmohsen, K., Li, X. L., Zhu, Y. J., Daulatabad, S. V., Tsitsipatis, D., Meltzer, P. S., et al. (2020) · Molecular and Cellular Biology · doi:10.1128/mcb.00473-19 · Cited by 33
Regulation of DNA Damage Response and Homologous Recombination Repair by microRNA in Human Cells Exposed to Ionizing Radiation
Szatkowska, M., & Krupa, R. (2020) · Cancers · doi:10.3390/cancers12071838 · Cited by 33
Exploring the p53 connection of cervical cancer pathogenesis involving north-east Indian patients
Khan, M. A., Tiwari, D., Dongre, A., Sadaf, S., Mustafa, S., Das, C. R., Massey, S., Bose, P. D., Bose, S., & Husain, S. A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0238500 · Cited by 32
Mutated p53 in HGSC—From a Common Mutation to a Target for Therapy
Saleh, A., & Perets, R. (2021) · Cancers · doi:10.3390/cancers13143465 · Cited by 33
Thymol has anticancer effects in U-87 human malignant glioblastoma cells
Seraj, F. Q. M., Heravi-Faz, N., Soltani, A., Ahmadi, S. S., shahbeiki, F., Talebpour, A., Afshari, A. R., Ferns, G. A., & Bahrami, A. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07867-3 · Cited by 32
Haploinsufficiency of ribosomal proteins and p53 activation in anemia: Diamond-Blackfan anemia and the 5q- syndrome
Boultwood, J., Pellagatti, A., & Wainscoat, J. S. (2011) · Advances in Biological Regulation · doi:10.1016/j.advenzreg.2011.09.008 · Cited by 32
P53 Family Members Modulate the Expression of PRODH, but Not PRODH2, via Intronic p53 Response Elements
Raimondi, I., Ciribilli, Y., Monti, P., Bisio, A., Pollegioni, L., Fronza, G., Inga, A., & Campomenosi, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069152 · Cited by 32
The RNA helicase/transcriptional co-regulator, p68 (DDX5), stimulates expression of oncogenic protein kinase, Polo-like kinase-1 (PLK1), and is associated with elevated PLK1 levels in human breast cancers
Iyer, R. S., Nicol, S. M., Quinlan, P., Thompson, A. M., Meek, D. W., & Fuller-Pace, F. V. (2014) · Cell Cycle · doi:10.4161/cc.28415 · Cited by 32
Mathematical modelling of p53 basal dynamics and DNA damage response
Chong, K. H., Samarasinghe, S., & Kulasiri, D. (2014) · Mathematical Biosciences · doi:10.1016/j.mbs.2014.10.010 · Cited by 30
Yin Yang 1 Promotes Thymocyte Survival by Downregulating p53
Chen, L., Foreman, D., Sant’Angelo, D. B., & Krangel, M. S. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501916 · Cited by 30
Nutlin‐3a selects for cells harbouring TP 53 mutations
Kucab, J. E., Hollstein, M. C., Arlt, V. M., & Phillips, D. H. (2016) · International Journal of Cancer · doi:10.1002/ijc.30504 · Cited by 31
SLMP53-2 Restores Wild-Type-Like Function to Mutant p53 through Hsp70: Promising Activity in Hepatocellular Carcinoma
Gomes, S., Bosco, B., Loureiro, J. B., Ramos, H., Raimundo, L., Soares, J., Nazareth, N., Barcherini, V., Domingues, L., Oliveira, C., et al. (2019) · Cancers · doi:10.3390/cancers11081151 · Cited by 31
Nutlin-Induced Apoptosis Is Specified by a Translation Program Regulated by PCBP2 and DHX30
Rizzotto, D., Zaccara, S., Rossi, A., Galbraith, M. D., Andrysík, Z., Pandey, A., Sullivan, K. D., Quattrone, A., Espinosa, J. M., Dassi, E., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.03.011 · Cited by 28
Estrogen prevents cellular senescence and bone loss through Usp10-dependent p53 degradation in osteocytes and osteoblasts: the role of estrogen in bone cell senescence
Yu, W., Fu, J., Wu, W., Ma, P., Ren, L., & Wu, J. (2021) · Cell and Tissue Research · doi:10.1007/s00441-021-03496-7 · Cited by 31
Pro-apoptotic effect ofPersea americanavar.Hass(avocado) on Jurkat lymphoblastic leukemia cells
Bonilla-Porras, A. R., Salazar-Ospina, A., Jiménez-Del-Río, M., Pereañez-Jimenez, A., & Velez‐Pardo, C. (2013) · Pharmaceutical Biology · doi:10.3109/13880209.2013.842599 · Cited by 31
Nanoparticle-mediated p53 gene therapy for tumor inhibition
Sharma, B., Ma, W., Adjei, I. M., Panyam, J., Dimitrijevic, S., & Labhasetwar, V. D. (2011) · Drug Delivery and Translational Research · doi:10.1007/s13346-010-0008-9 · Cited by 31
Igf2 pathway dependency of the Trp53 developmental and tumour phenotypes
Haley, V., Barnes, D., Sandovici, I., Constância, M., Graham, C. F., Pezzella, F., Bühnemann, C., Carter, E. J., & Hassan, A. B. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201101105 · Cited by 30
DNA double‐strand breaks induce the expression of flavin‐containing monooxygenase and reduce root meristem size in A rabidopsis thaliana
Chen, P., & Umeda, M. (2015) · Genes to Cells · doi:10.1111/gtc.12255 · Cited by 31
Self-citation
Human Cytomegalovirus pUL29/28 and pUL38 Repression of p53-Regulated p21CIP1 and Caspase 1 Promoters during Infection
Savaryn, J. P., Reitsma, J. M., Bigley, T. M., Halligan, B. D., Qian, Z., Yu, D. L., & Terhune, S. S. (2012) · Journal of Virology · doi:10.1128/jvi.01926-12 · Cited by 30
Residual apoptotic activity of a tumorigenic p53 mutant improves cancer therapy responses
Timofeev, O. N., Klimovich, B., Schneikert, J., Wanzel, M., Pavlakis, E., Noll, J., Mutlu, S., Elmshäuser, S., Nist, A., Mernberger, M., et al. (2019) · The EMBO Journal · doi:10.15252/embj.2019102096 · Cited by 31
TP53-inducible putative long noncoding RNAs encode functional polypeptides that suppress cell proliferationPreprint
Xu, W., Liu, C., Deng, B., Lin, P., Sun, Z., Liu, A., Xuan, J., Li, Y., Zhou, K., Zhang, X., et al. (2022) · Genome Research · doi:10.1101/gr.275831.121 · Cited by 30
A Comparison of Methods for RNA-Seq Differential Expression Analysis and a New Empirical Bayes Approach
Wesołowski, S., Birtwistle, M. R., & Rempała, G. A. (2013) · Biosensors · doi:10.3390/bios3030238 · Cited by 30
Crosstalk between the DNA damage response pathway and microRNAs
Han, C., Wan, G., Langley, R. R., Zhang, X., & Lu, X. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-0959-8 · Cited by 31
Fuzzy Tandem Repeats Containing p53 Response Elements May Define Species-Specific p53 Target Genes
Simeonova, I., Lejour, V., Bardot, B., Bouarich-Bourimi, R., Morin, A., Fang, M., Charbonnier, L., & Toledo, F. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002731 · Cited by 34
The role of mRNA decay in p53-induced gene expression
Melanson, B. D., Bose, R., Hamill, J. D., Marcellus, K. A., Pan, E., & McKay, B. C. (2011) · RNA · doi:10.1261/rna.030122.111 · Cited by 30
Interferon-Stimulated Gene 15 in the Control of Cellular Responses to Genotoxic Stress
Jeon, Y. J., Park, J. H., & Chung, C. H. (2017) · Molecules and Cells · doi:10.14348/molcells.2017.0027 · Cited by 30
The Emerging Role of the SLCO1B3 Protein in Cancer Resistance
Sun, R., Ying, Y., Tang, Z., Liu, T., Shi, F., Li, H., Guo, T., Huang, S., & Lai, R. (2019) · Protein and Peptide Letters · doi:10.2174/0929866526666190926154248 · Cited by 30
The Clinical Relevance of p16 and p53 Status in Patients with Squamous Cell Carcinoma of the Vulva
Barlow, E. L., Lambie, N., Donoghoe, M. W., Naing, Z., & Hacker, N. F. (2020) · Journal of Oncology · doi:10.1155/2020/3739075 · Cited by 30
Phosphorylation Control of p53 DNA-Binding Cooperativity Balances Tumorigenesis and Aging
Timofeev, O. N., Koch, L., Niederau, C., Tscherne, A., Schneikert, J., Klimovich, M., Elmshäuser, S., Zeitlinger, M. A., Mernberger, M., Nist, A., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-2002 · Cited by 31
The Topoisomerase 1 Inhibitor Austrobailignan-1 Isolated from Koelreuteria henryi Induces a G2/M-Phase Arrest and Cell Death Independently of p53 in Non-Small Cell Lung Cancer Cells
Wu, C., Huang, K., Yang, T., Li, Y., Wen, C.-L., Hsu, S., & Chen, T.-H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132052 · Cited by 29
Leucine‐rich hydrophobic clusters promote folding of the N‐terminus of the intrinsically disordered transactivation domain of p53
Espinoza-Fonseca, M. (2009) · FEBS Letters · doi:10.1016/j.febslet.2008.12.060 · Cited by 30
PRAP1 is a novel executor of p53-dependent mechanisms in cell survival after DNA damage
Huang, B., Zhuo, J., Leung, C. H., Lu, G., Liu, J. J., Yap, C. T., & Hooi, S. C. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.180 · Cited by 33
Human single-nucleotide polymorphisms alter p53 sequence-specific binding at gene regulatory elements
Bandele, O. J., Wang, X., Campbell, M. R., Pittman, G. S., & Bell, D. A. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq764 · Cited by 30
Autophagy process is associated with anti-neoplastic function
Wang, C., Wang, Y., McNutt, M. A., & Zhu, W. (2011) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmr028 · Cited by 31
Induction of Human UDP-Glucuronosyltransferase 2B7 Gene Expression by Cytotoxic Anticancer Drugs in Liver Cancer HepG2 Cells
Hu, D. G., Mackenzie, P. I., Lu, L., Meech, R., & McKinnon, R. A. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.062380 · Cited by 30
FOXO3a mediates the cytotoxic effects of cisplatin in lung cancer cells
Liu, H., Yin, J., Wang, C., Gu, Y., Deng, M., & He, Z. (2014) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000117 · Cited by 30
Global re‐wiring of p53 transcription regulation by the hepatitis B virus X protein
Chan, C. S. C., Thurnherr, T., Wang, J., Gallart‐Palau, X., Sze, S. K., Rozen, S., & Lee, C. G. L. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.05.006 · Cited by 30
FOXO3a orchestrates glioma cell responses to starvation conditions and promotes hypoxia-induced cell death
Brucker, D. P., Maurer, G. D., Harter, P. N., Rieger, J., & Steinbach, J. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3760 · Cited by 29
The PRR11-SKA2 Bidirectional Transcription Unit Is Negatively Regulated by p53 through NF-Y in Lung Cancer Cells
Wang, S., Weng, H., Zhang, Y., Long, Y., Li, Y., Niu, Y., Song, F., & Bu, Y. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030534 · Cited by 31
ADP-ribosylation and intracellular traffic: an emerging role for PARP enzymes
Grimaldi, G., & Corda, D. (2019) · Biochemical Society Transactions · doi:10.1042/bst20180416 · Cited by 30
S100B protein as a possible participant in the brain metastasis of NSCLC
Pang, X., Min, J., Liu, L., Liu, Y., Ma, N., & Zhang, H. (2012) · Medical Oncology · doi:10.1007/s12032-012-0169-0 · Cited by 30
Telomerase-Specific Virotheranostics for Human Head and Neck Cancer
Kurihara, Y., Watanabe, Y., Onimatsu, H., Kojima, T., Shirota, T., Hatori, M., Liu, D., Kyo, S., Mizuguchi, H., Urata, Y., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2690 · Cited by 30
Introduction of exogenous wild‑type p53 mediates the regulation of oncoprotein�18/stathmin signaling via nuclear factor‑κB in non‑small cell lung cancer NCI‑H1299 cells
Chen, S., Zhao, Y., Shen, F., Long, D., Yu, T., & Lin, X. (2019) · Oncology Reports · doi:10.3892/or.2019.6964 · Cited by 29
Mechanotransduction for therapeutic approaches: Cellular aging and rejuvenation
Han, H.-M., Kim, S.-Y., & Kim, D. (2025) · APL Bioengineering · doi:10.1063/5.0263236 · Cited by 30
Multiple spatially related pharmacophores define small molecule inhibitors of OLIG2 in glioblastoma
Tsigelny, I. F., Mukthavaram, R., Kouznetsova, V. L., Chao, Y. S., Babić, I., Nurmemmedov, E., Pastorino, S., Jiang, P., Calligaris, D., Agar, N. Y. R., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5633 · Cited by 30
Sensitive DsRed fluorescence-based reporter cell systems for genotoxicity and oxidative stress assessment
Hendriks, G., Atallah, M., Raamsman, M., Morolli, B., van der Putten, H., Jaadar, H., Tijdens, I. B., Esveldt, R. E., Mullenders, L. H. F., van de Water, B., et al. (2011) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2011.02.013 · Cited by 29
MSK2 negatively regulates p53 activity in the absence of stress
Llanos, S., Cuadrado, A., & Serrano, M. (2009) · Science Signaling · doi:10.1126/scisignal.2000205 · Cited by 27
The melanoma-associated antigen MAGE-D2 suppresses TRAIL receptor 2 and protects against TRAIL-induced apoptosis in human melanoma cells
Tseng, H., Chen, L. H., Ye, Y., Tay, K. H., Jiang, C. C., Guo, S., Jin, L., Hersey, P., & Zhang, X. D. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs236 · Cited by 29
Human papillomavirus oncogenic E6 protein regulates human β-defensin 3 (hBD3) expression via the tumor suppressor protein p53
Dasgupta, T., Nweze, E. I., Yue, H., Wang, L., Jin, J., Ghosh, S. K., Kawsar, H. I., Zender, C. A., Androphy, E. J., Weinberg, A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8443 · Cited by 29
Sanshool from Zanthoxylum L. induces apoptosis in human hepatocarcinoma HepG2 cells
You, Y., Zhou, M., Lu, H., Shirima, G. G., Cheng, Y., & Xiong, L. (2015) · Food Science and Biotechnology · doi:10.1007/s10068-015-0289-3 · Cited by 29
Tumor-Associated Antigen xCT and Mutant-p53 as Molecular Targets for New Combinatorial Antitumor Strategies
Magri, J., Gasparetto, A., Conti, L., Calautti, E., Cossu, C., Ruiu, R., Barutello, G., & Cavallo, F. (2021) · Cells · doi:10.3390/cells10010108 · Cited by 31
Isoform-Specific Roles of Mutant p63 in Human Diseases
Osterburg, C., Osterburg, S., Zhou, H., Missero, C., & Dötsch, V. (2021) · Cancers · doi:10.3390/cancers13030536 · Cited by 28
p53 mutation alters the effect of the esophageal tumor suppressor KLF5 on keratinocyte proliferation
Yang, Y., Tarapore, R. S., Jarmel, M. H., Tétreault, M.-P., & Katz, J. P. (2012) · Cell Cycle · doi:10.4161/cc.22265 · Cited by 29
ERK1/2 activation mediated by the nutlin-3-induced mitochondrial translocation of p53
Lee, S., Shin, S. J., & Kim, H. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1764 · Cited by 29
Preferential binding of p53 tumor suppressor to p21 promoter sites that contain inverted repeats capable of forming cruciform structure
Coufal, J., Jagelská, E. B., Liao, J. C. C., & Brázda, V. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.10.015 · Cited by 27
All eukaryotes: Before turning off G1-S transcription, please check your DNA
de Bruin, R. A. M., & Wittenberg, C. (2009) · Cell Cycle · doi:10.4161/cc.8.2.7412 · Cited by 33
Transcriptional Regulation in Melanoma
Mitra, D., & Fisher, D. E. (2009) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2009.03.003 · Cited by 30
FOXO1 Mediates Advanced Glycation End Products Induced Mouse Osteocyte-Like MLO-Y4 Cell Apoptosis and Dysfunctions
Zhang, C., Wei, W., Chi, M., Wan, Y., Li, X., Qi, M., & Zhou, Y. (2019) · Journal of Diabetes Research · doi:10.1155/2019/6757428 · Cited by 29
Neoplasia
Stricker, T. P., & KUMAR, V. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0792-2.50012-2 · Cited by 28
Tetramerization‐defects of p53 result in aberrant ubiquitylation and transcriptional activity
Lang, V., Pallara, C., Zabala‐Letona, A., Lobato-Gil, S., Lopitz‐Otsoa, F., Farrás, R., Hjerpe, R., Torres-Ramos, M., Zabaleta, L., Blattner, C., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.04.002 · Cited by 29
Phosphorylation of Daxx by ATM contributes to DNA damage-induced p53 activation.
Tang, J., Agrawal, T., Cheng, Q., Qu, L., Brewer, M. D., Chen, J., & Yang, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055813 · Cited by 28
PRMT1 promotes Warburg effect by regulating the PKM2/PKM1 ratio in non-small cell lung cancer
Lu, P., Zhao, Y., Tan, J., Hou, J., Jin, X., Liu, D., Huang, B., & Lü, J. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06898-x · Cited by 28
Gatekeeper Between Quiescence and Differentiation
Quadrato, G., & Giovanni, S. D. (2012) · International review of neurobiology · doi:10.1016/b978-0-12-398309-1.00005-6 · Cited by 28
Human pregnane X receptor compromises the function of p53 and promotes malignant transformation
Robbins, D. F., Cherian, M. T., Wu, J., & Chen, T. (2016) · Cell Death Discovery · doi:10.1038/cddiscovery.2016.23 · Cited by 28
Hypoxia-independent gene expression signature associated with radiosensitisation of prostate cancer cell lines by histone deacetylase inhibition
Jonsson, M., Ragnum, H. B., Halle, C., Yeramian, A., Clancy, T., Frikstad, K.-A. M., Seierstad, T., Stokke, T., Matías‐Guiu, X., Ree, A. H., et al. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.278 · Cited by 28
PANDAR: a pivotal cancer-related long non-coding RNA in human cancers
Li, J., Li, Z., Zheng, W., Li, X., Wang, Z., Cui, Y., & Jiang, X. (2017) · Molecular BioSystems · doi:10.1039/c7mb00414a · Cited by 28
Inhibition of miR‐34a‐5p can rescue disruption of the p53‐DAPK axis to suppress progression of clear cell renal cell carcinoma
Jing, Z., Bi, J., Li, Z., Liu, X., Li, J., Zhu, Y., Zhang, X., Zhang, Z., Li, Z., & Kong, C. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12545 · Cited by 28
Reduced FOXF1 links unrepaired DNA damage to pulmonary arterial hypertension
Isobe, S., Nair, R. V., Kang, H. Y., Wang, L., Moonen, J.-R. A. J., Shinohara, T., Cao, A., Taylor, S., Otsuki, S., Marciano, D. P., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43039-y · Cited by 32
RNPC1, an RNA-binding Protein and a p53 Target, Regulates Macrophage Inhibitory Cytokine-1 (MIC-1) Expression through mRNA Stability
Yin, T., Cho, S.-J., & Chen, X. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.480186 · Cited by 28
Regulation of APCCdh1 E3 ligase activity by the Fbw7/cyclin E signaling axis contributes to the tumor suppressor function of Fbw7
Lau, A. W., Inuzuka, H., Fukushima, H., Wan, L., Liu, P., Gao, D., Sun, Y., & Wei, W. (2013) · Cell Research · doi:10.1038/cr.2013.67 · Cited by 28
Anti-apoptosis Proteins Mcl-1 and Bcl-xL Have Different p53-Binding Profiles
Yao, H., Mi, S., Gong, W., Lin, J., Xu, N., Perrett, S., Xia, B., Wang, J., & Feng, Y. (2013) · Biochemistry · doi:10.1021/bi400690m · Cited by 28
CHIP-dependent p53 regulation occurs specifically during cellular senescence
Sisoula, C., Trachana, V., Patterson, C., & Gonos, E. S. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.10.701 · Cited by 29
Variable structure motifs for transcription factor binding sites
Reid, J. E., Evans, K. J., Dyer, N. P., Wernisch, L., & Ott, S. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-30 · Cited by 27
GSIV serine/threonine kinase can induce apoptotic cell death via p53 and pro-apoptotic gene Bax upregulation in fish cells
Reshi, L., Wu, H.-C., Wu, J., Wang, H., & Hong, J. (2016) · APOPTOSIS · doi:10.1007/s10495-016-1219-4 · Cited by 28
Association of insertion-deletions polymorphisms with colorectal cancer risk and clinical features
Marques, D., Ferreira-Costa, L. R., Ferreira-Costa, L. L., Corrêa, R. D. S., Borges, A. M. P., Ito, F. R., Ramos, C. C. D. O., Bortolin, R. H., Luchessi, A. D., Ribeiro‐dos‐Santos, Â., et al. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i37.6854 · Cited by 28
HMGA2 promotes intestinal tumorigenesis by facilitating MDM2‐mediated ubiquitination and degradation of p53
Wang, Y., Hu, L. T., Wang, J., Li, X., Sahengbieke, S., Wu, J., & Lai, M. (2018) · The Journal of Pathology · doi:10.1002/path.5164 · Cited by 29
Abrogation of FBW7α-dependent p53 degradation enhances p53’s function as a tumor suppressor
Tripathi, V., Kaur, E., Kharat, S. S., Hussain, M., Damodaran, A. P., Kulshrestha, S., & Sengupta, S. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ac119.008483 · Cited by 28
Transcriptional factors Eaf1/2 inhibit endoderm and mesoderm formation via suppressing TGF-β signaling
Liu, J., Xu, Q.-H., Li, S., Yu, X., Liu, W., Ouyang, G., Zhang, T., & Chen, L. (2017) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2017.09.001 · Cited by 28
Why Does Binding of Proteins to DNA or Proteins to Proteins Not Necessarily Spell Function?
Ma, B., Tsai, C., Pan, Y., & Nussinov, R. (2010) · ACS Chemical Biology · doi:10.1021/cb900293a · Cited by 28
Cooperative interactions between p53 and NFκB enhance cell plasticity
Bisio, A., Zámborszky, J., Zaccara, S., Lion, M., Tebaldi, T., Sharma, V., Raimondi, I., Alessandrini, F., Ciribilli, Y., & Inga, A. (2014) · Oncotarget · doi:10.18632/oncotarget.2545 · Cited by 27
RCC2 is a novel p53 target in suppressing metastasis
Song, C. H., Li, L., Jin, Y., Li, Y., Liu, Y., Guo, L., Wu, C., Yun, C.-H., & Yin, Y. (2017) · Oncogene · doi:10.1038/onc.2017.306 · Cited by 27
Post-translational modifications of HOX proteins, an underestimated issue
Draime, A., Bridoux, L., Graba, Y., & Rezsöhazy, R. (2018) · The International Journal of Developmental Biology · doi:10.1387/ijdb.180178rr · Cited by 26
Salvation of the fallen angel: Reactivating mutant p53
Yang, L., Wang, Z., Chen, Y., Petersen, R. B., Zheng, L., & Huang, K. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14572 · Cited by 27
Oridonin induces Mdm2‐p60 to promote p53‐mediated apoptosis and cell cycle arrest in neuroblastoma
Zhu, H., Zhang, C., Zhu-ying, G., Yang, J., Guo, J., Chen, C., Yao, Q., Liu, F., Zhang, Q., & Gao, F. (2019) · Cancer Medicine · doi:10.1002/cam4.2393 · Cited by 27
Mutant P53 induces MELK expression by release of wild-type P53-dependent suppression of FOXM1
Bollu, L. R., Shepherd, J. H., Zhao, D., Ma, Y., Tahaney, W. M., Speers, C. W., Mazumdar, A., Mills, G. B., & Brown, P. H. (2020) · npj Breast Cancer · doi:10.1038/s41523-019-0143-5 · Cited by 27
P53-independent partial restoration of the p53 pathway in tumors with mutated p53 through ATF4 transcriptional modulation by ERK1/2 and CDK9
Tian, X., Ahsan, N., Lulla, A. R., Lev, A., Abbosh, P. H., Dicker, D. T., Zhang, S., & El‐Deiry, W. S. (2021) · Neoplasia · doi:10.1016/j.neo.2021.01.004 · Cited by 27
The emerging and diverse roles of the SLy/SASH1‐protein family in health and disease—Overview of three multifunctional proteins
Jaufmann, J., Franke, F. C., Sperlich, A., Blumendeller, C., Kloos, I., Schneider, B., Sasaki, D., Janssen, K., & Beer‐Hammer, S. (2021) · The FASEB Journal · doi:10.1096/fj.202002495r · Cited by 25
Effects of tris (2-chloroethyl) phosphate (TCEP) on survival, growth, histological changes and gene expressions in juvenile yellow catfish Pelteobagrus fulvidraco
Zhao, Y., Yin, L., Dong, F., Zhang, W., & Hu, F. (2021) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2021.103699 · Cited by 27
p53-Dependent Repression: DREAM or Reality?
Peuget, S., & Selivanova, G. (2021) · Cancers · doi:10.3390/cancers13194850 · Cited by 27
Transcription Factor Oscillations Induce Differential Gene Expressions
Wee, K. B., Yio, W. K., Surana, U., & Chiam, K. (2012) · Biophysical Journal · doi:10.1016/j.bpj.2012.04.023 · Cited by 27
p53 in cell invasion, podosomes, and invadopodia
Mak, A. S. (2014) · Cell Adhesion & Migration · doi:10.4161/cam.27841 · Cited by 28
Ral GTPase Down-regulation Stabilizes and Reactivates p53 to Inhibit Malignant Transformation
Tecleab, A., Zhang, X., & Sebti, S. M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.565796 · Cited by 27
Increased aldehyde reductase expression mediates acquired radioresistance of laryngeal cancer cells via modulating p53
Kim, J., Chang, J. W., Park, J. K., & Hwang, S. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.20081 · Cited by 27
The A2Aadenosine receptor rescues neuritogenesis impaired by p53 blockage via KIF2A, a kinesin family member
Sun, C., Chuang, H., Wang, J., Chen, S.-S., Cheng, Y., Lee, C.-F., & Chern, Y. (2010) · Developmental Neurobiology · doi:10.1002/dneu.20802 · Cited by 27

Authors: Riley, T., Sontag, E., Chen, P., & Levine, A.
Affiliations: Institute for Advanced Study (US)
Rutgers, The State University of New Jersey (US)
Corresponding author: Riley, Todd
ORCID: Sontag, Eduardo
Chen, Patricia
Levine, Arnold
Venue: Nature Reviews Molecular Cell Biology
Publisher: Springer Science and Business Media LLC
Published: 2008-05
Volume: 9
Issue: 5
Pages: 402-412
ISSN: 1471-0072 (ISSN-L)
1471-0080
DOI: 10.1038/nrm2395
OpenAlex: W1964719993
Cited by: 1,921
References: 201
Citations by year: 2026: 36 · 2025: 45 · 2024: 56 · 2023: 73 · 2022: 85 · 2021: 97 · 2020: 79 · 2019: 92 · 2018: 110 · 2017: 134 · 2016: 131 · 2015: 115 · 2014: 154 · 2013: 143 · 2012: 153
FWCI: 12.97
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Reviews Molecular Cell Biology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
Keywords: p53, transcriptional regulation, p53 target genes, DNA damage response, DNA repair, cell cycle arrest, senescence, apoptosis, tumor suppression, transcription factor binding sites, stress signaling
MeSH terms: Base Sequence, Binding Sites, Cell Transformation, Neoplastic, DNA Damage, Gene Expression Regulation, Humans, Markov Chains, Molecular Sequence Data, Regulatory Sequences, Nucleic Acid, Transcription, Genetic, Signal Transduction, Genes, p53, Tumor Suppressor Protein p53, Response Elements, Regulatory Elements, Transcriptional

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Transcriptional control of human p53-regulated genes

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks